ARQT
Arcutis Biotherapeutics, Inc.Company with tickers: ARQT
CIK
1787306
CUSIP
03969K108
Shares Outstanding
125,083,374
13F Activity (30d)
233 filings
229 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-11 | Vairavan Latha | SVP Chief Financial Officer | Sell | 435 |
| 2026-05-11 | Burnett Patrick | Chief Medical Officer | Sell | 222 |
| 2026-05-04 | Burnett Patrick | Chief Medical Officer | Sell | 684 |
| 2026-05-04 | Vairavan Latha | SVP Chief Financial Officer | Sell | 1,341 |
| 2026-05-04 | Watanabe Todd | Director, See Remarks | Other | 25,410 |
| 2026-05-04 | Watanabe Todd | Director, See Remarks | Sell | 3,172 |
| 2026-05-04 | Watanabe Todd | Director, See Remarks | Other | 57,358 |
| 2026-05-04 | Watanabe Todd | Director, See Remarks | Other | 124,956 |
| 2026-05-04 | Watanabe Todd | Director, See Remarks | Other | 25,410 |
| 2026-05-04 | Matsuda Masaru | SVP, General Counsel | Sell | 7,372 |
| 2026-05-04 | Matsuda Masaru | SVP, General Counsel | Sell | 884 |
| 2026-05-01 | Welgus Howard G. | Director | Sell | 7,144 |
| 2026-04-01 | Welgus Howard G. | Director | Sell | 10,000 |
| 2026-03-02 | Edwards Larry Todd | See Remarks | Sell | 103 |
| 2026-03-02 | Edwards Larry Todd | See Remarks | Sell | 3,584 |
| 2026-03-02 | Welgus Howard G. | Director | Sell | 10,000 |
| 2026-03-02 | Vairavan Latha | SVP Chief Financial Officer | Sell | 81 |
| 2026-03-02 | Vairavan Latha | SVP Chief Financial Officer | Sell | 2,772 |
| 2026-03-02 | Leonard Keith R | Director | Convert | 12,220 |
| 2026-03-02 | Leonard Keith R | Director | Convert | 27,052 |
| 2026-03-02 | Leonard Keith R | Director | Sell | 39,272 |
| 2026-03-02 | Leonard Keith R | Director | Convert | 12,220 |
| 2026-03-02 | Leonard Keith R | Director | Other | 1,750 |
| 2026-03-02 | Leonard Keith R | Director | Convert | 27,052 |
| 2026-03-02 | Watanabe Todd | Director, See Remarks | Sell | 36,281 |
| 2026-03-02 | Watanabe Todd | Director, See Remarks | Sell | 1,068 |
| 2026-03-02 | Matsuda Masaru | SVP, General Counsel | Sell | 193 |
| 2026-03-02 | Matsuda Masaru | SVP, General Counsel | Sell | 6,553 |
| 2026-03-02 | Matsuda Masaru | SVP, General Counsel | Sell | 1,987 |
| 2026-03-02 | Burnett Patrick | Chief Medical Officer | Sell | 6,106 |
| 2026-03-02 | Burnett Patrick | Chief Medical Officer | Sell | 181 |
| 2026-02-27 | Edwards Larry Todd | See Remarks | Award | 30,000 |
| 2026-02-27 | Edwards Larry Todd | See Remarks | Award | 77,000 |
| 2026-02-27 | Burnett Patrick | Chief Medical Officer | Award | 77,000 |
| 2026-02-27 | Vairavan Latha | SVP Chief Financial Officer | Award | 70,000 |
| 2026-02-27 | Vairavan Latha | SVP Chief Financial Officer | Award | 27,000 |
| 2026-02-27 | Watanabe Todd | Director, See Remarks | Other | 124,956 |
| 2026-02-27 | Watanabe Todd | Director, See Remarks | Other | 25,410 |
| 2026-02-27 | Watanabe Todd | Director, See Remarks | Other | 25,410 |
| 2026-02-27 | Watanabe Todd | Director, See Remarks | Award | 102,000 |
| 2026-02-27 | Watanabe Todd | Director, See Remarks | Award | 266,000 |
| 2026-02-27 | Watanabe Todd | Director, See Remarks | Other | 57,358 |
| 2026-02-27 | Matsuda Masaru | SVP, General Counsel | Sell | 3,325 |
| 2026-02-27 | Matsuda Masaru | SVP, General Counsel | Award | 37,000 |
| 2026-02-27 | Matsuda Masaru | SVP, General Counsel | Award | 97,000 |
| 2026-02-27 | Burnett Patrick | Chief Medical Officer | Award | 30,000 |
| 2026-02-04 | Burnett Patrick | Chief Medical Officer | Sell | 9,794 |
| 2026-02-02 | Edwards Larry Todd | See Remarks | Sell | 2,052 |
| 2026-02-02 | Matsuda Masaru | SVP, General Counsel | Sell | 4,714 |
| 2026-02-02 | Matsuda Masaru | SVP, General Counsel | Sell | 7,983 |
| 2026-02-02 | Matsuda Masaru | SVP, General Counsel | Sell | 8,562 |
| 2026-02-02 | Matsuda Masaru | SVP, General Counsel | Sell | 19,379 |
| 2026-02-02 | Burnett Patrick | Chief Medical Officer | Sell | 3,675 |
| 2026-02-02 | Watanabe Todd | Director, See Remarks | Sell | 19,833 |
| 2026-02-02 | Watanabe Todd | Director, See Remarks | Other | 124,956 |
| 2026-02-02 | Watanabe Todd | Director, See Remarks | Other | 25,410 |
| 2026-02-02 | Watanabe Todd | Director, See Remarks | Other | 25,410 |
| 2026-02-02 | Watanabe Todd | Director, See Remarks | Other | 57,358 |
| 2026-02-02 | Vairavan Latha | SVP Chief Financial Officer | Sell | 1,320 |
| 2026-02-02 | Welgus Howard G. | Director | Sell | 10,000 |
| 2026-01-05 | Burnett Patrick | Chief Medical Officer | Sell | 2,490 |
| 2026-01-02 | Welgus Howard G. | Director | Sell | 10,000 |
| 2025-12-31 | Burnett Patrick | Chief Medical Officer | Sell | 1,156 |
| 2025-12-31 | Burnett Patrick | Chief Medical Officer | Sell | 541 |
| 2025-12-15 | Burnett Patrick | Chief Medical Officer | Convert | 11,500 |
| 2025-12-15 | Burnett Patrick | Chief Medical Officer | Convert | 11,500 |
| 2025-12-15 | Burnett Patrick | Chief Medical Officer | Sell | 11,500 |
| 2025-12-04 | Munshi Amit | Director | Award | 6,177 |
| 2025-12-04 | Munshi Amit | Director | Award | 2,021 |
| 2025-12-04 | Munshi Amit | Director | Award | 16,502 |
| 2025-12-04 | Munshi Amit | Director | Other | 2,000 |
| 2025-12-01 | Matsuda Masaru | SVP, General Counsel | Sell | 1,657 |
| 2025-12-01 | Welgus Howard G. | Director | Sell | 10,000 |
| 2025-11-24 | Watanabe Todd | Director, See Remarks | Sell | 48,945 |
| 2025-11-24 | LIN SUE-JEAN | Director | Convert | 18,052 |
| 2025-11-24 | LIN SUE-JEAN | Director | Sell | 25,272 |
| 2025-11-24 | LIN SUE-JEAN | Director | Convert | 7,220 |
| 2025-11-24 | LIN SUE-JEAN | Director | Convert | 7,220 |
| 2025-11-24 | LIN SUE-JEAN | Director | Convert | 18,052 |
| 2025-11-21 | Watanabe Todd | Director, See Remarks | Sell | 1,055 |
| 2025-11-21 | Watanabe Todd | Director, See Remarks | Other | 25,410 |
| 2025-11-21 | Watanabe Todd | Director, See Remarks | Other | 25,410 |
| 2025-11-21 | Watanabe Todd | Director, See Remarks | Other | 124,956 |
| 2025-11-21 | Watanabe Todd | Director, See Remarks | Other | 57,358 |
| 2025-11-20 | Gilbert Halley E | Director | Convert | 12,220 |
| 2025-11-20 | Gilbert Halley E | Director | Sell | 16,532 |
| 2025-11-20 | Gilbert Halley E | Director | Convert | 12,220 |
| 2025-11-19 | Matsuda Masaru | SVP, General Counsel | Sell | 989 |
| 2025-11-19 | Matsuda Masaru | SVP, General Counsel | Sell | 1,561 |
| 2025-11-13 | Krishnamohan Neha | Chief Financial Officer | Convert | 12,220 |
| 2025-11-13 | Krishnamohan Neha | Chief Financial Officer | Sell | 39,272 |
| 2025-11-13 | Krishnamohan Neha | Chief Financial Officer | Convert | 12,220 |
| 2025-11-13 | Krishnamohan Neha | Chief Financial Officer | Sell | 1,232 |
| 2025-11-13 | Krishnamohan Neha | Chief Financial Officer | Convert | 27,052 |
| 2025-11-13 | Krishnamohan Neha | Chief Financial Officer | Convert | 27,052 |
| 2025-11-13 | Leonard Keith R | Director | Other | 1,750 |
| 2025-11-13 | Leonard Keith R | Director | Gift | 4,312 |
| 2025-11-06 | Edwards Larry Todd | See Remarks | Sell | 29,131 |
| 2025-11-06 | Burnett Patrick | Chief Medical Officer | Sell | 17,250 |
| 2025-11-06 | Burnett Patrick | Chief Medical Officer | Convert | 17,250 |